North Star Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
RJA
FHA
CAN
AG
North Star Asset Management's HQL Position: Q3 2018 in Review
North Star Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q3 2018, closing a stake of 10,130 shares — an estimated $190K sold.
North Star Asset Management first reported a position in HQL in Q2 2013 and held it in 21 quarters. The position peaked at $541K in Q2 2014. 57 funds tracked by Wall St. Rank hold HQL as of Q3 2018.
- North Star Asset Management reported no remaining abrdn Life Sciences Investors position as of Q3 2018 after selling out during the quarter.
- North Star Asset Management sold 10,130 abrdn Life Sciences Investors shares in Q3 2018, an estimated $190K.
- North Star Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 21 quarters.
- North Star Asset Management's abrdn Life Sciences Investors position peaked at $541K in Q2 2014.
- 57 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2018.
Based on North Star Asset Management's 13F filing for Q3 2018, filed 29 Oct 2018.